CD274 and neoplasm: Currently, few studies have evaluated whether clinical features affect PD-L1 expression and whether tumor sampling procedures, such as sample type (e.g., biopsy and resection), sample site, and prior antitumor therapy affect PD-L1 expression [12, 13].